We are live on !
Find out more
DA
DCF Advisers Portfolio holdings
AUM
$566M
Turnover
17.35%
1-Year Est. Return
197.74%
This Fund
S&P 500
This Quarter Est. Return
+96.59%
1 Year Est. Return
+197.74%
3 Year Est. Return
+371.51%
5 Year Est. Return
+473.27%
10 Year Est. Return
–
AUM
$566M
AUM Growth
+$191M
(+51%)
Cap. Flow
-$25.1M
Cap. Flow % of AUM
Cap. Flow %
-4.43%
Top 10 Holdings %
Top 10 Hldgs %
65.92%
Holding
98
New
12
Increased
27
Reduced
22
Closed
5
Avg Time Held
Equity + Options
2.4
years
Top 10 Avg Time Held
Equity + Options
2
years
Top 20 Avg Time Held
Equity + Options
2.3
years
Avg Time Held Equity only
2.8
years
Top 10 Avg Time Held Equity only
2.3
years
Top 20 Avg Time Held Equity only
2.8
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$5.33M |
| 2 |
HELP
Helus Pharma Inc. Common Stock
HELP
|
+$3.72M |
| 3 |
Microsoft
MSFT
|
+$3.33M |
| 4 |
Immuneering
IMRX
|
+$3.28M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
+$1.99M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Micron Technology
MU
|
+$37.5M |
| 2 |
Eli Lilly
LLY
|
+$5.72M |
| 3 |
Cisco
CSCO
|
+$1.57M |
| 4 |
Teva Pharmaceutical Industries Limited
TEVA
|
+$1.52M |
| 5 |
Ionis Pharmaceuticals
IONS
|
+$1.39M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 38.15% |
| 2 | Technology | 31.31% |
| 3 | Healthcare | 17.63% |
| 4 | Communication Services | 4.62% |
| 5 | Consumer Discretionary | 4.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
26
Zoom
ZM
$29.3B
| $4.39M | 0.78% |
50,875
+4,375
| +9% | +$414K |
2024 Q2
8 quarters
|
|
27
Intel
INTC
$505B
| $3.98M | 0.7% |
28,500
-6,500
| -19% | -$657K |
2023 Q1
13 quarters
|
|
|
28
Immuneering
IMRX
$258M
| $3.94M | 0.7% |
790,000
+648,538
| +458% | +$3.28M |
2025 Q4
2 quarters
|
|
29
Alibaba
BABA
$251B
| $3.79M | 0.67% |
39,500
+1,000
| +3% | +$125K |
2025 Q4
2 quarters
|
|
|
30
Microsoft
MSFT
$3.94T
| $3.63M | 0.64% |
9,725
+8,225
| +548% | +$3.33M |
2026 Q1
1 quarter
|
|
31
Uber
UBER
$133B
| $3.61M | 0.64% |
50,000
-5,000
| -9% | -$367K |
2025 Q4
2 quarters
|
|
32
Lam Research
LRCX
$318B
| $3.25M | 0.57% |
7,500
| – | – |
2023 Q2
12 quarters
|
|
|
33
Eli Lilly
LLY
$1.15T
| $3.24M | 0.57% |
2,700
-5,600
| -67% | -$5.72M |
2020 Q4
22 quarters
|
|
34
Evotec
EVO
$569M
| $3.02M | 0.53% |
1,079,024
+13,750
| +1% | +$39.7K |
2023 Q1
13 quarters
|
|
|
35
Ionis Pharmaceuticals
IONS
$7.46B
| $2.97M | 0.53% |
37,500
-18,500
| -33% | -$1.39M |
2024 Q2
8 quarters
|
|
36
abrdn Total Dynamic Dividend Fund
AOD
$1.07B
| $2.74M | 0.48% |
266,000
| – | – |
2019 Q4
26 quarters
|
|
37
AbbVie
ABBV
$505B
| $2.71M | 0.48% |
10,750
| – | – |
2019 Q4
26 quarters
|
|
38
Broadcom
AVGO
$1.68T
| $2.69M | 0.48% |
7,125
+2,250
| +46% | +$902K |
2024 Q2
8 quarters
|
|
39
Zimmer Biomet
ZBH
$18.4B
| $2.63M | 0.46% |
30,500
| – | – |
2023 Q2
12 quarters
|
|
40
Nuveen Credit Strategies Income Fund
JQC
$670M
| $2.57M | 0.45% |
528,113
+51,777
| +11% | +$250K |
2022 Q2
16 quarters
|
|
41
VanEck Junior Gold Miners ETF
GDXJ
$7.75B
| $2.46M | 0.43% |
25,000
| – | – |
2022 Q4
14 quarters
|
|
|
42
CALL
Microsoft
MSFT
$3.94T
| $2.31M | 0.41% |
6,200
+5,200
| +520% | +$2.1M |
2026 Q1
1 quarter
|
|
43
Lifecore Biomedical
LFCR
$247M
| $2.23M | 0.39% |
424,500
| – | – |
2023 Q2
12 quarters
|
|
44
Barrick Mining
B
$65.3B
| $2.2M | 0.39% |
60,000
| – | – |
2025 Q4
2 quarters
|
|
45
iShares Silver Trust
SLV
$26.4B
| $2.14M | 0.38% |
40,000
| – | – |
2020 Q3
23 quarters
|
|
46
MarineMax
HZO
$1.16B
| $2.11M | 0.37% |
+57,500
| New | +$1.85M |
2026 Q2
0 quarters
|
|
47
Barnes & Noble Education
BNED
$448M
| $2.06M | 0.36% |
164,383
-32,560
| -17% | -$340K |
2024 Q2
8 quarters
|
|
48
CALL
Biohaven
BHVN
$2.34B
| $2M | 0.35% |
134,500
| – | – |
2025 Q3
3 quarters
|
|
|
49
Biohaven
BHVN
$2.34B
| $1.93M | 0.34% |
130,000
+6,500
| +5% | +$70K |
2024 Q2
8 quarters
|
|
50
Amgen
AMGN
$244B
| $1.9M | 0.34% |
5,250
-750
| -13% | -$257K |
2023 Q1
13 quarters
|
|
Similar funds
LT
DCF Advisers's Q2 2026 Portfolio in Review
As of Q2 2026, DCF Advisers held 98 positions worth $566M, up 51% from $375M the previous quarter. Its ten largest holdings account for 66% of the portfolio.
DCF Advisers withdrew a net $25.1M in Q2 2026, closing 5 positions and reducing 22 holdings. Its most notable exit was Synopsys, an estimated $496K position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 38% of assets, down from 38% a quarter earlier, followed by Technology and Healthcare.
Against the trend, DCF Advisers opened a new position in MarineMax worth $2.11M.
- DCF Advisers's largest Q2 2026 buy was MarineMax: 57,500 shares worth $2.11M.
- DCF Advisers added most to Amazon in Q2 2026, an estimated $5.33M increase.
- DCF Advisers's biggest Q2 2026 reduction was Micron Technology, cutting an estimated $37.5M.
- DCF Advisers fully exited Synopsys in Q2 2026, selling an estimated $496K.
- DCF Advisers's ten largest holdings make up 66% of its $566M portfolio in Q2 2026.
- DCF Advisers opened 12 new positions and closed 5 in Q2 2026.
- DCF Advisers's portfolio value rose 51% quarter-over-quarter to $566M.
Based on DCF Advisers's 13F filing for Q2 2026, filed 10 Aug 2026.